date:May 15, 2012
g trial with spontaneously hypertensive rats indicated positivein vivoresults when the rats were given 60mg hydrolysate/kg body weight per day.
Although furtherin vivostudies are necessary to verify the antihypertensive potential, the very highin vitroACE inhibitory activity reveals that the shrimp protein hydrolysate is a promising candidate for nutraceutical application.
Nofino is a part government, part industry-funded research group. It worked with Norwegian supplier, Marealis, which par